PURE Bioscience reports fiscal third quarter 2014 financial results
date:Jun 12, 2014
7 million, respectively.

The net loss for the third fiscal quarter of 2014 was $(2.1) million, or $(0.07) per share, compared with a net loss of $(1.5) million, or $(0.14) per share, in the third fiscal quarter of 2013.

Revenues for the nine months ended April 30, 2014 were $417,000, compared with revenues of $631,000 for the nine months ended April 30, 2013. Total operating costs and expenses, excluding share-based compensation, other share-based expense, and restructuring costs, were $4.4 mi
2/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/10 03:17